Inhibition of APOE potentiates immune checkpoint therapy for cancer

Checkpoint immunotherapy is capable of unleashing T cells for controlling tumor, whereas it is destroyed by immunosuppressive myeloid cell. Apoprotein E (APOE) refers to a ligand in terms of the members of low-density lipoprotein (LDL) receptor family for mediating Apoprotein B-involving atherogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Bingqing, Lu, Chen, Li, Haiyang, Hao, Xiaopei, Liu, Hanyuan, Zhuo, Danping, Wang, Qian, Li, Zhouxiao, Liu, Li, Wang, Xuehao, Gu, Yanhong, Tang, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461658/
https://www.ncbi.nlm.nih.gov/pubmed/36147474
http://dx.doi.org/10.7150/ijbs.70117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461658/
https://www.ncbi.nlm.nih.gov/pubmed/36147474
http://dx.doi.org/10.7150/ijbs.70117

Ejemplares similares